Results 171 to 180 of about 2,265 (188)
Some of the next articles are maybe not open access.
Tezepelumab (Tezspire) for severe asthma.
The Medical letter on drugs and therapeutics, 2022openaire +1 more source
SEVERE EGPA – A ROLE FOR TEZEPELUMAB?
Annals of Allergy, Asthma & ImmunologyR. Crawford +4 more
openaire +1 more source
Tezepelumab therapy: hints toward a disease-modifying effect?
Medicom Conference Report ERS 2023, 2023openaire +1 more source
Tezepelumab prepares to enter the asthma antibody fray
Nature Reviews Drug Discovery, 2021openaire +1 more source
Tezepelumab in active osteoarthritis with asthma
Journal of Allergy and Clinical ImmunologyRoberto Colli +2 more
openaire +1 more source